A case-study for Poland.
A brief presentation of the preliminary results from EUReMS’ PRO study.
The European Medicines Agency’s (EMA) Isabelle Moulon explains the role of the organisation.
EMSP’s Deputy CEO Christoph Thalheim presented the opportunities available for EMSP, partners and sponsors to follow-up on our completed EUReMS...
A seminar on Better access to therapies and care in Central and Eastern European countries, organised by EMSP in November 2010, in...
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.